CEO departure is bad timing for Medical Facilities Corp, says Canaccord Genuity

An abrupt exit for its CEO has left Canaccord Genuity analyst Neil Maruoka wondering just how deep Medical Facilities Corp’s (Medical Facilities Corp.Stock Quote, Chart, News: TSX:DR) bench is.

Yesterday, Medical Facilities Corp. announced its president and chief executive officer Britt T. Reynolds left the corporation and resigned as a member of the board. The company said board member Jeffrey Lozon would fill the role of interim CEO, beginning immediately.

“We are pleased that Jeff is stepping into this role,” said board chair Marilynne Day-Linton. “His leadership experience in both the U.S. and Canadian health care markets, as well as his knowledge of MFC’s business and strategy, make him well suited to direct the corporation through this transition. The company’s growth strategy and the strong expertise in both the senior management team and leadership at the centres securely positions MFC for continued success.”

Maruoka says the company’s value proposition just took on a lot more risk.

“Given the abruptness of the departure and the lack of details provided, we assume that his exit was related to a disagreement with the board,” says the analyst. “Regardless, we believe this news comes at a bad time for Medical Facilities, as the company is just starting to show signs of margin stability after several quarters of weakness; moreover, MFC has struggled to integrate Unity, which was a recent acquisition driven largely by the former CEO. Mr. Reynolds will be replaced on an interim basis by board member Jeffrey Lozon; however, given that it took months to identify Mr. Reynolds, we believe that leadership uncertainty could linger. We expect the stock will trade lower on this news, but we also believe it will eventually find support from its current 6.9% yield. Nonetheless, given the leadership uncertainty and the unfortunate timing, we see significantly higher risks for shareholders in the near term.”

In a research update to clients today, Maruoka downgraded Medical Facilities Corp from “Buy” to “Hold” and lowered his one-year price target on the stock from $22.50 to $17.00, implying a return of 10.7 per cent at the time of publication.

Maruoka thinks Medical Facilities Corp will generate EBITDA of $105.9-million on reveneu of $378.4-million in fiscal 2017. He expects the company will post EBITDA of $113.9-million on a topline of $375.9-million the following year.

We Hate Paywalls Too!

At Cantech Letter we prize independent journalism like you do. And we don't care for paywalls and popups and all that noise That's why we need your support. If you value getting your daily information from the experts, won't you help us? No donation is too small.

Make a one-time or recurring donation

Tagged with: dr
Nick Waddell

Cantech Letter founder and editor Nick Waddell has lived in five Canadian provinces and is proud of his country's often overlooked contributions to the world of science and technology. Waddell takes a regular shift on the Canadian media circuit, making appearances on CTV, CBC and BNN, and contributing to publications such as Canadian Business and Business Insider.

Recent Posts

Is GOOGL still a buy?

Following a widely applauded first quarter beat, Roth MKM analyst Rohit Kulkarni has maintained his "Buy" rating on Alphabet (Alphabet… [Read More]

4 mins ago

NLH has 173% upside, Echelon says

Following an acquisition, Echelon Capital Markets analyst Stefan Quenneville has maintained his "Buy" rating on Nova Leap Health (Nova Leap… [Read More]

41 mins ago

Shopify upgraded to “Buy” at Citi

The stock has been flat since November, but Citi analyst Tyler Radke thinks there is now money to be made… [Read More]

1 hour ago

Sabio has 400% upside, Eight Capital says

Following the company's fourth quarter results, Eight Capital analyst Kiran Sritharan has maintained his "Buy" rating on Sabio Holdings (Sabio… [Read More]

3 days ago

Is SNAP a buy right now?

He feels the company made forward progress in its recent quarterly results, but Roth MKM analyst Rohit Kulkarni wants to… [Read More]

3 days ago

Bombardier wins price target raise at Desjardins

Following the company's first quarter results, Desjardins analyst Benoit Poirier has raised his price target on Bombardier (Bombardier Stock Quote,… [Read More]

3 days ago